Company / Accounts Receivable
Vaxart, Inc. Accounts Receivable History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$14.6M
FY2025
5-year range
$630.0K / $14.6M
FY2021-FY2025
Trend
+152.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has increased for 3 consecutive years, from $630,000 in FY2017 to $15M in FY2025.
Based on SEC 10-K filings.
$15M in FY2025 with a 10-year CAGR of +1.5%.
Improved from $2M to $15M over the past 7 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +1.5%
Key checks
Key Insights
- Vaxart, Inc.'s accounts receivable has grown for 3 consecutive years.
- In FY2025, accounts receivable increased 152.8% year-over-year.
- Peak accounts receivable was recorded in FY2014.
- Lowest accounts receivable in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.04 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.6M | +152.8% |
| FY2024 | $5.8M | +220.8% |
| FY2018 | $1.8M | +185.1% |
| FY2017 | $630.0K | -10.0% |
| FY2016 | $700.0K | -94.4% |
| FY2015 | $12.6M | -32.6% |
| FY2014 | $18.7M | +70.0% |
| FY2013 | $11.0M | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026